| 2025 |
Muñoz, F. M., Avila Aguero, M. L., Cutland, C. L., Dinleyici, E. C., Eckert, L. O., Giles, M. L., . . . Heath, P. T. (2025). Fostering Collaboration Across Nations: Report of the 6th International Neonatal and Maternal Immunization Symposium (INMIS), Costa Rica, 2024. Pediatric Infectious Disease Journal, 44(2), S2-S8.
DOI |
| 2025 |
McAlister, S. M., van den Biggelaar, A. H. J., Cooper, M. N., Thornton, R., Richmond, P., Marshall, H. S., . . . Wood, N. (2025). Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses.. The Pediatric infectious disease journal, 44(5), 476-483.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Ryan, F. J., Clarke, M., Lynn, M. A., Benson, S. C., McAlister, S., Giles, L. C., . . . Lynn, D. J. (2025). Bifidobacteria support optimal infant vaccine responses. Nature, 641(8062), 456-464.
DOI Scopus17 WoS17 Europe PMC11 |
| 2025 |
Pham-Tran, D. D., Leong, L. E. X., McMillan, M., Lawrence, A., Mohammed, H., Finn, A., & Marshall, H. S. (2025). The lack of specificity of
<i>sodC</i>
-based PCR for the detection of
<i>Neisseria meningitidis</i>
carriage in pharyngeal swabs from adolescents. Microbiology Spectrum, 13(5), 8 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
DuBray, K., Phan, K., Anglemyer, A., Burell, R., Blyth, C. C., Carr, J., . . . Britton, P. N. (2025). The Spectrum and Burden of COVID-19-Associated Neurologic Disease in Australian Children 2020-2023. Pediatric Infectious Disease Journal, 44(9), 882-888.
DOI |
| 2025 |
White, E., Baik, M. K., Zahir, S. F., Blyth, C. C., Carr, J., Crawford, N. W., . . . Clark, J. E. (2025). Management and outcomes of children hospitalised with COVID-19 including incidental and nosocomial infections in Australia 2020–2023: A national surveillance study. Journal of Clinical Virology, 179, 105824.
DOI Scopus1 WoS1 |
| 2025 |
Wang, B., Giles, L., Andraweera, P., McMillan, M., Beazley, R., Almond GradCert, S., . . . Marshall, H. (2025). Long-term protection against invasive meningococcal B disease and gonococcal infection five years after implementation of funded childhood and adolescent 4CMenB vaccination program in South Australia: an observational cohort and case-control study.. Clin Infect Dis, 81(4), e202-e210.
DOI Scopus3 WoS2 Europe PMC2 |
| 2025 |
Andraweera, P. H., Wang, B., Danchin, M., Blyth, C. C., Vlaev, I., Ong, J. J., . . . Marshall, H. S. (2025). Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in Australia. Vaccine, 62, 9 pages.
DOI |
| 2025 |
Munoz, F. M., Kampmann, B., Stergachis, A., Chaudhary, M., Cutland, C. L., Khalil, A., . . . Muelen, A. S. T. (2025). A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women. Vaccine, 62, 11 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Coldbeck-Shackley, R. C., Lawrence, A., McMillan, M., Selway, C. A., Papanicolas, L., Turra, M., . . . Leong, L. E. X. (2025). Direct whole-genome sequencing enables strain typing of unculturable Neisseria meningitidis from oropharyngeal carriage specimens. Microbial genomics, 11(8), 001464-1-001464-14.
DOI |
| 2025 |
Wang, B., Andraweera, P., Danchin, M., Blyth, C. C., Vlaev, I., Ong, J. J., . . . Marshall, H. S. (2025). Nudging towards COVID-19 and influenza vaccination in children with medically at-risk conditions. Journal of Public Health, 47(4), fdaf097-1-fdaf097-12.
DOI |
| 2025 |
Milazzo, A., & Marshall, H. S. (2025). Invasive Meningococcal Disease Outbreak Management. Pediatric Infectious Disease Journal, 44(11), e407-e409.
DOI |
| 2025 |
Koirala, A., Prasad, S. A., Britton, P. N., Wood, N., Richmond, P. C., McMullan, B., . . . Bolsewicz, K. (2025). Understanding motivation and experience in participating in a paediatric SARS-CoV-2 serosurvey, in Australia. Vaccine X, 27, 6 pages.
DOI |
| 2025 |
Clarke, M., McMillan, M., Giles, L. C., Riley, K., Andraweera, P., Richmond, P. C., . . . Marshall, H. S. (2025). The impact of obesity on influenza Vaccine immunogenicity: A systematic review. Vaccine, 65, 127794.
DOI |
| 2025 |
Andani, A., Abbing-Karahagopian, V., Kavaliauskaite, J., Schaffner, T. O., Sohn, W. Y., Graña, M. G., . . . Taha, M. K. (2025). Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention. Human Vaccines and Immunotherapeutics, 21(1), 16 pages.
DOI |
| 2025 |
Probert, J., Dodwell, D., Broggio, J., Coleman, R., Marshall, H., Darby, S. C., & Mannu, G. S. (2025). Identification of recurrences in women diagnosed with early invasive breast cancer using routinely collected data in England. BJC REPORTS, 3(1), 12 pages.
DOI |
| 2025 |
Chaudhary, M., Cutland, C. L., Bonet, M., Gentile, A., Jones, C. E., Marshall, H. S., . . . Munoz, F. M. (2025). Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine, 43(Pt 1), 11 pages.
DOI Scopus4 WoS4 Europe PMC4 |
| 2025 |
Clarke, M., & Marshall, H. S. (2025). A step closer to elimination of meningococcal disease.. The Lancet. Infectious diseases, 25(4), 360-362.
DOI |
| 2025 |
Marshall, H. S., Molina, J. M., Berlaimont, V., Mulgirigama, A., Sohn, W. Y., Berçot, B., & Bobde, S. (2025). Management and prevention of Neisseria meningitidis and Neisseria gonorrhoeae infections in the context of evolving antimicrobial resistance trends. European Journal of Clinical Microbiology and Infectious Diseases, 44(2), 233-250.
DOI Scopus5 WoS3 Europe PMC3 |
| 2025 |
Sullivan, S. G., Khvorov, A., Carolan, L., Dowson, L., Hadiprodjo, A. J., Sánchez-Ovando, S., . . . Fox, A. (2025). Antibody responses against influenza A decline with successive years of annual influenza vaccination.. npj Vaccines, 10(1), 11-1-11-10.
DOI Scopus6 WoS5 Europe PMC6 |
| 2025 |
Wang, B., Lassi, Z., Andraweera, P., Chen, G., Ong, J. J., McMillian, M., & Marshall, H. (2025). Pregnant women's choices for preventing respiratory syncytial virus (RSV). Vaccine, 48, 7 pages.
DOI Scopus1 WoS2 Europe PMC1 |
| 2025 |
Mohammed, H., Riley, K., Clarke, M., Walker, M. S., & Marshall, H. S. (2025). Provider Determinants of Maternal Influenza and Pertussis Vaccination Uptake in South Australia in a Tertiary Healthcare Setting. Journal of Clinical Medicine, 14(3), 890.
DOI Scopus1 |
| 2025 |
Messina, N. L., Germano, S., Chung, A. W., van de Sandt, C. E., Stevens, N. E., Allen, L. F., . . . BRACE Trial Consortium Group. (2025). Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination. Clinical & Translational Immunology, 14(1), e70023-1-e70023-18.
DOI Scopus3 WoS3 Europe PMC3 |
| 2025 |
McRae, J. E., Huang, Y. A., Khair Baik, M., Wood, N., Hassall, J., Tsang, T., . . . Kynaston, A. (2025). COVID-19 and Influenza Deaths in Australian Children 2018-2023: A National Case Analysis. Journal of the Pediatric Infectious Diseases Society, 14(11).
DOI |
| 2024 |
McLeod, C., Dymock, M., Flanagan, K. L., Plebanski, M., Marshall, H., Marsh, J., . . . Richmond, P. (2024). The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocol. Trials, 25(1), 735-1-735-10.
DOI |
| 2024 |
Clarke, M., Mathew, S. M., Giles, L. C., Barr, I. G., Richmond, P. C., & Marshall, H. S. (2024). The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During Pregnancy. Vaccines, 12(12), 1307-1-1307-13.
DOI Scopus2 WoS1 |
| 2024 |
McLeod, C., Dymock, M., Flanagan, K. L., Plebanski, M., Marshall, H. S., Estcourt, M. J., . . . Richmond, P. C. (2024). The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old. Journal of Infection, 89(6), 106346-1-106346-10.
DOI Scopus3 WoS1 |
| 2024 |
Wang, B., Giles, L., Andraweera, P., McMillan, M., Beazley, R., Sisnowski, J., . . . Marshall, H. (2024). Long-term 4CMenB vaccine effectiveness against gonococcal infection at four years post program implementation: observational case-control study. Open Forum Infectious Diseases, 12(1), ofae726-1-ofae726-7.
DOI Scopus6 WoS3 Europe PMC6 |
| 2024 |
Wilkins, K., Ivanova, K., Marshall, H., Bennett, L., & Anderton, J. (2024). Stories and systems: Exploring technological impact in complex systems through creative writing techniques. TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 209, 8 pages.
DOI |
| 2024 |
Mohammed, H., Peut, C., McMillan, M., Wang, B., Sullivan, T. R., & Marshall, H. S. (2024). THE ROLE OF SCHOOLS IN MENINGOCOCCAL CARRIAGE AMONG ADOLESCENTS AND YOUNG ADULTS IN SOUTH AUSTRALIA.. Pediatr Infect Dis J, 43(7), e249-e251.
DOI |
| 2024 |
Messina, N. L., Germano, S., McElroy, R., Bonnici, R., Grubor-Bauk, B., Lynn, D. J., . . . Spotswood, J. (2024). Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines - an exploratory sub-study of the BRACE trial. eBioMedicine, 103, 105100-1-105100-16.
DOI Scopus7 WoS6 Europe PMC6 |
| 2024 |
Marshall, H., Ward, J., Wang, B., Andraweera, P., McMillan, M., Flood, L., . . . Lahra, M. M. (2024). Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol. BMJ Open, 14(5), e079144-1-e079144-8.
DOI Scopus2 WoS2 Europe PMC1 |
| 2024 |
Pittet, L. F., Messina, N. L., McDonald, E., Orsini, F., Barry, S., Bonten, M., . . . Ma, N. (2024). Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial. Eclinicalmedicine, 72, 102616.
DOI Scopus4 Europe PMC3 |
| 2024 |
McMillan, M., McDonough, J., Angliss, M., Buttery, J., Saunders, L., Mathew, S. M., . . . Marshall, H. S. (2024). Exploring the Health-Related Quality of Life and the Lived Experience of Adolescents Following Invasive Meningococcal Disease. Healthcare Switzerland, 12(11), 15 pages.
DOI Scopus3 WoS3 Europe PMC3 |
| 2024 |
Villanueva, P., Crawford, N. W., Croda, M. G., Croda, J., Dalcolmo, M., Jardim, B. A., . . . Curtis, N. (2024). Accelerated Bacille Calmette-Guérin reactions: More than meets the eye. Heliyon, 10(13), e32510-1-e32510-10.
DOI |
| 2024 |
Wang, B., Mohammed, H., Andraweera, P., McMillan, M., & Marshall, H. (2024). Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis. Journal of Infection, 89(3), 10 pages.
DOI Scopus14 WoS13 Europe PMC10 |
| 2024 |
Messina, N. L., Pittet, L. F., McDonald, E., Moore, C., Barry, S., Bonten, M., . . . Curtis, N. (2024). BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial. Journal of Infection, 89(4), 106245-1-106245-11.
DOI Scopus8 WoS6 Europe PMC5 |
| 2024 |
Morello, B. R., Milazzo, A., Marshall, H. S., & Giles, L. C. (2024). Public health management of invasive meningococcal disease outbreaks: worldwide 1973-2018, a systematic review. BMC Public Health, 24(1), 2254-1-2254 -11.
DOI Scopus6 WoS6 Europe PMC4 |
| 2024 |
Koirala, A., McRae, J., Britton, P. N., Downes, M., Prasad, S. A., Nicholson, S., . . . Macartney, K. (2024). The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A crosssectional study. PLoS ONE, 19(9 September), e0300555.
DOI Scopus3 WoS3 Europe PMC1 |
| 2024 |
Wang, B., Seib, K. L., & Marshall, H. (2024). The future role of vaccination in prevention of Neisseria gonorrhoeae. Microbiology Australia, 45(3), 117-121.
DOI Scopus1 WoS1 |
| 2024 |
McLeod, C., Dymock., Flanagan, K. L., Plebanski, M., Marshall, H., Estcourt, M. J., . . . Richmond, P. (2024). The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old. The Journal of infection, 89(6), 106286-1-106286-9.
DOI Scopus1 WoS2 Europe PMC1 |
| 2024 |
Lyu, Y., Choong, A., Chow, E. P. F., Seib, K. L., Marshall, H. S., Unemo, M., . . . Ong, J. J. (2024). Vaccine value profile for Neisseria gonorrhoeae.. Vaccine, 42(19), S42-S69.
DOI Scopus16 WoS15 Europe PMC13 |
| 2024 |
Leong, L. E. X., Coldbeck-Shackley, R. C., McMillan, M., Bratcher, H. B., Turra, M., Lawrence, A., . . . Marshall, H. (2024). The genomic epidemiology of Neisseria meningitidis carriage from a randomised controlled trial of 4CMenB vaccination in an asymptomatic adolescent population. The Lancet Regional Health. Western Pacific, 43, 10 pages.
DOI Scopus5 WoS5 Europe PMC2 |
| 2024 |
Milazzo, A., McMillan, M., Giles, L., Page, K., Flood, L., & Marshall, H. (2024). The geographic distribution of invasive meningococcal disease and carriage: A spatial analysis. Epidemiology and Infection, 152, e22-1-e22-11.
DOI |
| 2024 |
McMillan, M., Mohammed, H., Bednarz, J., Leong, L. E. X., Lawrence, A., Sullivan, T. R., . . . Marshall, H. S. (2024). Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020.. The Journal of infection, 88(2), S0163-4453(24)00021-5.
DOI Scopus3 WoS2 Europe PMC2 |
| 2024 |
Wang, B., Andraweera, P., Danchin, M., Blyth, C. C., Vlaev, I., Ong, J., . . . Marshall, H. (2024). Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinics. BMJ Open, 14(2), 076194-1-076194-9.
DOI Scopus2 WoS2 Europe PMC1 |
| 2024 |
Villanueva, P., McDonald, E., Croda, J., Croda, M. G., Dalcolmo, M., Dos Santos, G., . . . Curtis, N. (2024). Factors influencing adverse events following COVID-19 vaccination.. Human Vaccines and Immunotherapeutics, 20(1), 2323853-1-2323853-11.
DOI Scopus7 WoS8 Europe PMC6 |
| 2023 |
Andraweera, P. H., Wang, B., Danchin, M., Blyth, C., Vlaev, I., Ong, J., . . . Marshall, H. S. (2023). Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccines among pregnant women (the EPIC study): study protocol. Trials, 24(1), 454-1-454-8.
DOI Scopus3 WoS3 Europe PMC3 |
| 2023 |
Rahaman, M. R., Dear, K., Satter, S. M., Tong, M., Milazzo, A., Marshall, H., . . . Bi, P. (2023). Short-Term Effects of Climate Variability on Childhood Diarrhoea in Bangladesh: Multi-Site Time-Series Regression Analysis. International Journal of Environmental Research and Public Health, 20(13), 6279-1-6279-15.
DOI Scopus5 Europe PMC6 |
| 2023 |
Villanueva, P., Crawford, N. W., Croda, M. G., Collopy, S., Jardim, B. A., de Almeida Pinto Jardim, T., . . . Pittet, L. F. (2023). Erratum: Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination (Heliyon (2023) 9(4), (S2405844023024489), (10.1016/j.heliyon.2023.e15241)). Heliyon, 9(6), e15821.
DOI |
| 2023 |
Tuckerman, J., Riley, K., Straube, S., Mohammed, H., Danchin, M., & Marshall, H. S. (2023). Interventions for increasing the uptake of immunisations in healthcare workers: A systematic review. Vaccine, 41(38), 5499-5506.
DOI Scopus1 WoS1 |
| 2023 |
Villanueva, P., Crawford, N. W., Garcia Croda, M., Collopy, S., Araújo Jardim, B., de Almeida Pinto Jardim, T., . . . Pittet, L. F. (2023). Safety of BCG vaccination and revaccination in healthcare workers.. Human Vaccines and Immunotherapeutics, 19(2), 2239088.
DOI Scopus7 WoS7 Europe PMC6 |
| 2023 |
Wang, B., & Marshall, H. S. (2023). A new era for equity in meningococcal disease prevention.. Lancet Infect Dis, 23(12), 1329-1330.
DOI Scopus2 WoS1 Europe PMC1 |
| 2023 |
Homaira, N., Strachan, R., Quinn, H., Beggs, S., Bhuiyan, M., Bowen, A., . . . Snelling, T. (2023). Erratum to "Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study" [Vaccine 41(1) (2023) 85-91].. Vaccine, 41(42), 6401-6402.
DOI |
| 2023 |
Pittet, L. F., Moore, C. L., McDonald, E., Barry, S., Bonten, M., Campbell, J., . . . Hammond, C. (2023). Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial. Eclinicalmedicine, 64, 102203.
DOI Scopus5 Europe PMC4 |
| 2023 |
Burman, C., Findlow, J., Marshall, H. S., & Safadi, M. A. P. (2023). National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease. Expert review of vaccines, 22(1), 839-848.
DOI Scopus5 WoS4 Europe PMC4 |
| 2023 |
Liu, Y., Sánchez-Ovando, S., Carolan, L., Dowson, L., Khvorov, A., Hadiprodjo, J., . . . Fox, A. (2023). Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19.. medRxiv.
DOI |
| 2023 |
Liu, Y., Sánchez-Ovando, S., Carolan, L., Dowson, L., Khvorov, A., Jessica Hadiprodjo, A., . . . Fox, A. (2023). Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines. Vaccine, 41(48), 7192-7200.
DOI Scopus6 WoS6 Europe PMC7 |
| 2023 |
Homaira, N., Strachan, R., Quinn, H., Beggs, S., Bhuiyan, M., Bowen, A., . . . Snelling, T. (2023). Real World Impact of 13vPCV in Preventing Invasive Pneumococcal Pneumonia in Australian Children: A National Study. Vaccine, 41(1), 85-91.
DOI Scopus5 WoS6 Europe PMC5 |
| 2023 |
Mohammed, H., Pham-Tran, D. D., Yeoh, Z. Y. M., Wang, B., McMillan, M., Andraweera, P. H., & Marshall, H. S. (2023). A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529). Vaccines, 11(2), 1-19.
DOI Scopus36 WoS32 Europe PMC31 |
| 2023 |
Wang, B., Andraweera, P., Elliott, S., Mohammed, H., Lassi, Z., Twigger, A., . . . Marshall, H. (2023). Asymptomatic SARS-CoV-2 Infection by Age: A Global Systematic Review and Meta-analysis. The Pediatric Infectious Disease Journal, 42(3), 232-239.
DOI Scopus44 WoS38 Europe PMC41 |
| 2023 |
Tuckerman, J., Harper, K., Sullivan, T. R., Cuthbert, A. R., Fereday, J., Couper, J., . . . Marshall, H. S. (2023). Short Message Service Reminder Nudge for Parents and Influenza Vaccination Uptake in Children and Adolescents With Special Risk Medical Conditions: The Flutext-4U Randomized Clinical Trial.. JAMA Pediatr, 177(4), 337-344.
DOI Scopus16 WoS17 Europe PMC15 |
| 2023 |
McLeod, C., Ramsay, J., Flanagan, K. L., Plebanski, M., Marshall, H., Dymock, M., . . . Richmond, P. (2023). Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO).. Trials, 24(1), 14 pages.
DOI Scopus7 WoS6 Europe PMC5 |
| 2023 |
Yanni, M., Stark, M., Francis, L., Francis, J. R., McMillan, M., Baird, R., . . . Marshall, H. S. (2023). Neonatal Group B Streptococcal Infection in Australia: A Case-control Study.. The Pediatric Infectious Disease Journal, 42(5), 429-435.
DOI Scopus4 WoS4 Europe PMC3 |
| 2023 |
Bao, J., Nunez, C., Elliott, E., Dinsmore, N., McRae, J., Morris, A., . . . Britton, P. N. (2023). Acute Flaccid Paralysis in Australian Children from 2007 to 2017. Neuroepidemiology, 57(1), 25-34.
DOI Scopus1 WoS2 Europe PMC1 |
| 2023 |
Pittet, L. F., Messina, N. L., Orsini, F., Moore, C. L., Abruzzo, V., Barry, S., . . . BRACE Trial Consortium Group. (2023). Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers. The New England journal of medicine, 388(17), 1582-1596.
DOI Scopus90 WoS86 Europe PMC90 |
| 2023 |
Villanueva, P., Crawford, N. W., Croda, M. G., Collopy, S., Jardim, B. A., de Almeida Pinto Jardim, T., . . . Pittet, L. F. (2023). Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination. Heliyon, 9(4), e15241-1-e15241-12.
DOI Scopus6 WoS6 Europe PMC5 |
| 2023 |
Davies, C., Marshall, H. S., Brotherton, J. M. L., McCaffery, K., Kang, M., Macartney, K., . . . HPV.edu Study Group. (2023). Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial. Preventive Medicine, 172, 107542-1-107542-10.
DOI Scopus11 WoS10 Europe PMC10 |
| 2023 |
Wang, B., Giles, L., Andraweera, P., McMillan, M., Almond, S., Beazley, R., . . . Marshall, H. (2023). 4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post program implementation. Journal of Infection, 87(2), 95-102.
DOI Scopus39 WoS38 Europe PMC39 |
| 2023 |
Marshall, G. S., Abbing-Karahagopian, V., Marshall, H. S., Cenci, S., Conway, J. H., Occhipinti, E., . . . Sohn, W. -Y. (2023). A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB).. Expert Rev Vaccines, 22(1), 530-544.
DOI Scopus15 WoS13 Europe PMC15 |
| 2023 |
Wang, B., McDonough, J., Chen, G., Ong, J. J., & Marshall, H. (2023). Sociodemographic factors and attitudes associated with Australian parental acceptance of paediatric COVID-19 vaccination.. Vaccine, 41(51), 7608-7617.
DOI Scopus4 WoS4 Europe PMC3 |
| 2022 |
Koirala, A., Gidding, H. F., Vette, K., Macartney, K., Wood, N., Britton, P. N., . . . Archer, P. L. (2022). The seroprevalence of SARS-CoV-2-specific antibodies in children, Australia, November 2020 – March 2021. Medical Journal of Australia, 217(1), 43-45.
DOI Scopus11 Europe PMC10 |
| 2022 |
Marshall, H. (2022). Brain Fever: How Vaccines Prevent Meningitis and Other Killer Diseases. LANCET INFECTIOUS DISEASES, 22(3), 327.
DOI |
| 2022 |
Messina, N. L., Germano, S., McElroy, R., Rudraraju, R., Bonnici, R., Pittet, L. F., . . . Castro, G. C. E. (2022). Off-target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19. Clinical and Translational Immunology, 11(4), 1-15.
DOI Scopus33 |
| 2022 |
McMillan, M., Bednarz, J., Leong, L. E. X., Lawrence, A., & Marshall, H. S. (2022). Impact of COVID-19 Containment Strategies and Meningococcal Conjugate ACWY Vaccination on Meningococcal Carriage in Adolescents. Pediatric Infectious Disease Journal, 41(11), e468-e474.
DOI Scopus8 WoS8 Europe PMC7 |
| 2022 |
Marshall, H. S., Vesikari, T., Richmond, P. C., Wysocki, J., Szenborn, L., Beeslaar, J., . . . Perez, J. L. (2022). Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies.. Lancet Infectious Diseases, 23(1), 103-116.
DOI Scopus8 WoS8 Europe PMC7 |
| 2022 |
Chang, A. B., Toombs, M., Chatfield, M. D., Mitchell, R., Fong, S. M., Binks, M. J., . . . Grimwood, K. (2022). Study protocol for preventing early-onset pneumonia in young children through maternal immunisation: a multi-centre randomised controlled trial (PneuMatters). Frontiers in Pediatrics, 9, 781168-1-781168-12.
DOI Scopus3 WoS3 Europe PMC1 |
| 2022 |
Tuckerman, J., Harper, K., Sullivan, T. R., Fereday, J., Couper, J., Smith, N., . . . Marshall, H. (2022). Using provider-parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial protocol. BMJ Open, 12(2), 7 pages.
DOI Scopus2 WoS2 Europe PMC2 |
| 2022 |
Marshall, H. S., Andraweera, P. H., Ward, J., Kaldor, J., Andrews, R., Macartney, K., . . . Whop, L. (2022). An observational study to assess the effectiveness of 4CMenB against meningococcal disease and carriage and gonorrhea in adolescents in the Northern Territory, Australia—study protocol. Vaccines, 10(2), 309-1-309-13.
DOI Scopus11 WoS12 Europe PMC9 |
| 2022 |
Sheel, M., Wood, N., Macartney, K., Buttery, J., Dinsmore, N., Marshall, H., . . . McIntyre, P. (2022). Severity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007-2018. The Pediatric Infectious Disease Journal, 41(6), 507-513.
DOI Scopus7 WoS7 Europe PMC7 |
| 2022 |
Begum, H., Dwyer, D. E., Holmes, M., Irving, L., Simpson, G., Senenayake, S., . . . Cheng, A. (2022). Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN). Communicable diseases intelligence (2018), 46, 20 pages.
DOI Scopus4 WoS6 Europe PMC4 |
| 2022 |
Wang, B., Giles, L., Andraweera, P., McMillan, M., Almond, S., Beazley, R., . . . Marshall, H. (2022). Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study. The Lancet Infectious Diseases, 22(7), 1011-1020.
DOI Scopus76 WoS73 Europe PMC72 |
| 2022 |
Cheng, A. C., Dwyer, D. E., Holmes, M., Irving, L., Simpson, G., Senenayake, S., . . . Kelly, P. (2022). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN). Communicable diseases intelligence (2018), 46, 1-17.
DOI Scopus6 Europe PMC7 |
| 2022 |
Clarke, M., Mathew, S. M., Giles, L. C., Pena, A. S., Barr, I. G., Richmond, P. C., & Marshall, H. S. (2022). A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents. Vaccines, 10(5), 699-1-699-12.
DOI Scopus9 WoS10 Europe PMC8 |
| 2022 |
Gunaratna, G. P. S., Mohammad, S. S., Blyth, C. C., Clark, J., Crawford, N., Marshall, H., . . . Britton, P. N. (2022). Postinfectious Acute Cerebellar Syndromes in Children: A Nationally Ascertained Case Series From Australia 2013–2018. Journal of Child Neurology, 37(7), 617-623.
DOI Scopus3 WoS3 Europe PMC2 |
| 2022 |
Norman, D. A., Cheng, A. C., Macartney, K. K., Moore, H. C., Danchin, M., Seale, H., . . . Blyth, C. C. (2022). Influenza hospitalizations in Australian children 2010-2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness. Influenza and Other Respiratory Viruses, 16(2), 316-327.
DOI Scopus15 WoS15 Europe PMC13 |
| 2022 |
Rahaman, M. R., Hodgetts, K., Milazzo, A., Marshall, H., Chaber, A. -L., Crabb, D., & Bi, P. (2022). Q fever prevention in Australia: general practitioner and stakeholder perspectives on preparedness and the potential of a One Health approach.. Aust N Z J Public Health, 46(2), 96-202.
DOI Scopus5 WoS3 Europe PMC3 |
| 2022 |
Rahaman, M. R., Burgess, T., Marshall, H., Milazzo, A., Chaber, A. -L., Crabb, D., & Bi, P. (2022). Q fever prevention: perspectives from university animal science and veterinary students and livestock farmers. Australian Journal of Rural Health, 30(3), 385-392.
DOI Scopus2 WoS2 Europe PMC3 |
| 2022 |
Wang, B., Nolan, R., Krumeich, B., D'Onise, K., & Marshall, H. (2022). COVID-19 vaccine willingness prior to and during the COVID-19 vaccination rollout in Australia. Human Vaccines and Immunotherapeutics, 18(5), 1-9.
DOI Scopus7 WoS7 Europe PMC8 |
| 2022 |
Quinn, H. E., Comeau, J. L., Marshall, H. S., Elliott, E. J., Crawford, N. W., Blyth, C. C., . . . Wood, N. J. (2022). Pertussis disease and antenatal vaccine effectiveness in Australian children. The Pediatric Infectious Disease Journal, 41(3), 180-185.
DOI Scopus8 WoS7 Europe PMC7 |
| 2022 |
McMillan, M., Marshall, H. S., & Richmond, P. (2022). 4CMenB vaccine and its role in preventing transmission and inducing herd immunity. Expert Review of Vaccines, 21(1), 103-114.
DOI Scopus6 WoS5 Europe PMC6 |
| 2022 |
McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., Bednarz, J., MacLennan, J. M., . . . Marshall, H. S. (2022). 'B Part of It' School Leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with meningococcal B (4CMenB) vaccine on carriage of Neisseria meningitidis. Journal of Infectious Diseases, 225(4), 637-649.
DOI Scopus8 WoS8 Europe PMC6 |
| 2022 |
Stevens, N. E., van Wolfswinkel, M., Bao, W., Ryan, F. J., Brook, B., Amenyogbe, N., . . . Lynn, D. J. (2022). Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice. Vaccine, 40(11), 1594-1605.
DOI Scopus10 WoS10 Europe PMC8 |
| 2021 |
Martinón-Torres, F., Banzhoff, A., Azzari, C., De Wals, P., Marlow, R., Marshall, H., . . . Berkani, R. B. (2021). Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination: Real-world effectiveness of MenB vaccination.. The Journal of infection, 83(1), 17-26.
DOI Scopus40 WoS34 Europe PMC34 |
| 2021 |
Norman, D. A., Carlson, S. J., Tuckerman, J., Kaufman, J., Moore, H. C., Seale, H., . . . Danchin, M. (2021). The Collaboration for Increasing Influenza Vaccination in Children (CIIVIC): a meeting report. Australian and New Zealand Journal of Public Health, 45(3), 193-196.
DOI Scopus1 WoS1 Europe PMC2 |
| 2021 |
Oliver, J., Thielemans, E., McMinn, A., Baker, C., Britton, P. N., Clark, J. E., . . . Crawford, N. W. (2021). Correction to: Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study (BMC Public Health, (2019), 19, 1, (1750), 10.1186/s12889-019-8085-2). BMC Public Health, 21(1), 855.
DOI Europe PMC1 |
| 2021 |
Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Verburg, P., Dekker, G., & Marshall, H. S. (2021). Safety of maternal pertussis vaccination on pregnancy and birth outcomes: a prospective cohort study. Vaccine, 39(2), 324-331.
DOI Scopus13 WoS10 Europe PMC9 |
| 2021 |
Marshall, H. S., Andraweera, P. H., Wang, B., McMillan, M., Koehler, A. P., Lally, N., . . . Flood, L. (2021). Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol. Human Vaccines and Immunotherapeutics, 17(5), 1450-1454.
DOI Scopus13 WoS12 Europe PMC10 |
| 2021 |
Carlson, S. J., Quinn, H. E., Blyth, C. C., Cheng, A., Clark, J., Francis, J. R., . . . Leask, J. (2021). Barriers to influenza vaccination of children hospitalised for acute respiratory illness: a cross-sectional survey. Journal of Paediatrics and Child Health, 57(3), 409-418.
DOI Scopus9 WoS11 Europe PMC8 |
| 2021 |
McMillan, M., Walters, L., Sullivan, T., Leong, L. E. X., Turra, M., Lawrence, A., . . . Marshall, H. S. (2021). Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(1), e99-e106.
DOI Scopus20 WoS16 Europe PMC10 |
| 2021 |
Martinón-Torres, F., Banzhoff, A., Azzari, C., de Wals, P., Marlow, R., Marshall, H., . . . Bekkat-Berkani, R. (2021). Recent advances in the prevention of meningococcal B disease: real evidence from 4CMenB vaccination. Vacunas, 22(3), 189-202.
DOI Scopus1 |
| 2021 |
Mohammed, H., McMillan, M., Andraweera, P. H., Elliott, S. R., & Marshall, H. S. (2021). A rapid global review of strategies to improve influenza vaccination uptake in Australia.. Human vaccines & immunotherapeutics, 17(12), 1-13.
DOI Scopus13 WoS13 Europe PMC13 |
| 2021 |
Strachan, R., Homaira, N., Beggs, S., Bhuiyan, M. U., Gilbert, G. L., Lambert, S. B., . . . Jaffé, A. (2021). Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax, 76(5), 487-493.
DOI Scopus19 WoS19 Europe PMC17 |
| 2021 |
McMillan, M., Wang, B., Koehler, A. P., Sullivan, T. R., & Marshall, H. S. (2021). Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents.. Clin Infect Dis, 73(1), e233-e237.
DOI Scopus32 WoS27 Europe PMC23 |
| 2021 |
Rahaman, M. R., Marshall, H., Milazzo, A., Crabb, D., & Bi, P. (2021). Q fever prevention and vaccination: Australian livestock farmers' knowledge and attitudes to inform a One Health approach. One Health, 12, 100232-1-100232-9.
DOI Scopus11 WoS11 Europe PMC10 |
| 2021 |
Wurzel, D., McMinn, A., Hoq, M., Blyth, C. C., Burgner, D., Tosif, S., . . . Crawford, N. W. (2021). Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study. BMJ Open, 11(11), e054510-1-e054510-9.
DOI Scopus15 WoS13 Europe PMC13 |
| 2021 |
Whelan, J., Marshall, H., & Sullivan, T. R. (2021). Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics. PloS one, 16(10), 1-9.
DOI Scopus2 WoS2 Europe PMC4 |
| 2021 |
Davies, C., Marshall, H. S., Zimet, G., McCaffery, K., Brotherton, J. M. L., Kang, M., . . . Skinner, S. R. (2021). Effect of a school-based educational intervention about the human papillomavirus vaccine on psychosocial outcomes among adolescents: analysis of secondary outcomes of a cluster randomized trial. JAMA Network Open, 4(11), e2129057-1-e2129057-15.
DOI Scopus33 WoS31 Europe PMC27 |
| 2021 |
Madhi, S. A., Polack, F. P., Piedra, P. A., Munoz, F. M., Trenholme, A. A., Simões, E. A. F., . . . Fries, L. F. (2021). Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. Obstetrical and Gynecological Survey, 76(1), 10-13.
DOI Scopus1 |
| 2021 |
Davies, C., Stoney, T., Hutton, H., Parrella, A., Kang, M., Macartney, K., . . . Skinner, S. R. (2021). School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination. Vaccine, 39(40), 4190-4198.
DOI Scopus50 WoS50 Europe PMC46 |
| 2021 |
Morello, B. R., Milazzo, A., Marshall, H. S., & Giles, L. C. (2021). Lessons for and from the COVID-19 pandemic response — An appraisal of guidance for the public health management of Invasive Meningococcal Disease. Journal of Infection and Public Health, 14(8), 1069-1074.
DOI Scopus2 WoS2 Europe PMC2 |
| 2021 |
Clarke, M., Goodchild, L. M., Evans, S., Giles, L., Sullivan, S., Barr, I. G., . . . Marshall, H. (2021). Body mass index and vaccine responses following influenza vaccination during pregnancy.. Vaccine, 39(34), 4864-4870.
DOI Scopus6 WoS6 Europe PMC6 |
| 2021 |
Mohammed, H., McMillan, M., & Marshall, H. S. (2021). Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia. Human Vaccines & Immunotherapeutics, 18(1), 1-9.
DOI WoS1 |
| 2021 |
McHugh, L., O'Grady, K. A. F., Nolan, T., Richmond, P. C., Wood, N., Marshall, H. S., . . . Andrews, R. M. (2021). National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012–2015. Australian and New Zealand Journal of Public Health, 45(5), 455-461.
DOI Scopus12 WoS11 Europe PMC10 |
| 2021 |
Rahaman, M., Milazzo, A., Marshall, H., Chaber, A. -L., & Bi, P. (2021). Q fever vaccination: Australian animal science and veterinary students’ One Health perspectives on Q fever prevention. Human Vaccines and Immunotherapeutics, 17(5), 1374-1381.
DOI Scopus7 WoS5 Europe PMC4 |
| 2021 |
Burrell, R., Jones, C. A., Britton, P. N., Dale, R. C., Blyth, C. C., Clark, J. E., . . . Francis, J. (2021). Altered Behavior in Encephalitis: Insights From the Australian Childhood Encephalitis Study, 2013–2018. Frontiers in Pediatrics, 9.
DOI Scopus1 |
| 2021 |
Marshall, H. S. (2021). Meningococcal surveillance in Southeast Asia and the Pacific. Microbiology Australia, 42(4), 178-181.
DOI Scopus3 WoS3 |
| 2021 |
Wang, B., Nolan, R., & Marshall, H. (2021). Covid-19 immunisation, willingness to be vaccinated and vaccination strategies to improve vaccine uptake in Australia. Vaccines, 9(12), 1467.
DOI Scopus18 WoS21 Europe PMC19 |
| 2021 |
Dinsmore, N., McRae, J. E., Quinn, H. E., Glover, C., Dougherty, S., McMinn, A., . . . Wood, N. (2021). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious paediatric conditions.. Communicable diseases intelligence (2018), 45, 24 pages.
DOI WoS9 Europe PMC7 |
| 2020 |
Hiscox, L., Johnson, C. L., McGarry, M. D. J., Marshall, H., Ritchie, C. W., van Beek, E. J. R., . . . Starr, J. M. (2020). Mechanical property alterations across the cerebral cortex due to Alzheimer's disease. BRAIN COMMUNICATIONS, 2(1), 16 pages.
DOI WoS69 |
| 2020 |
Parikh, S. R., Campbell, H., Bettinger, J. A., Harrison, L. H., Marshall, H. S., Martinon-Torres, F., . . . Ladhani, S. N. (2020). The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. Journal of Infection, 81(4), 483-498.
DOI Scopus219 WoS188 Europe PMC157 |
| 2020 |
McRae, J. E., Quinn, H. E., Saravanos, G. L., Carlson, S. J., Britton, P. N., Crawford, N. W., . . . Macartney, K. K. (2020). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions. Communicable diseases intelligence (2018), 44, 21 pages.
DOI Scopus6 WoS9 Europe PMC8 |
| 2020 |
Top, K. A., Macartney, K., Bettinger, J. A., Tan, B., Blyth, C. C., Marshall, H. S., . . . McIntyre, P. (2020). Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia. Eurosurveillance, 25(25), 1-12.
DOI Scopus14 WoS15 Europe PMC14 |
| 2020 |
Tuckerman, J. L., Kaufman, J., Danchin, M., & Marshall, H. S. (2020). Influenza vaccination: a qualitative study of practice level barriers from medical practitioners caring for children with special risk medical conditions. Vaccine, 38(49), 7806-7814.
DOI Scopus6 WoS4 Europe PMC5 |
| 2020 |
McMillan, M., Chandrakumar, A., Wang, H. L. R., Clarke, M., Sullivan, T. R., Andrews, R. M., . . . Marshall, H. S. (2020). Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(3), E609-E619.
DOI Scopus52 WoS44 Europe PMC36 |
| 2020 |
Rahaman, M. R., Milazzo, A., Marshall, H., & Bi, P. (2020). Spatial, temporal, and occupational risks of Q fever infection in South Australia, 2007-2017.. Journal of infection and public health, 13(4), 544-551.
DOI Scopus11 WoS12 Europe PMC8 |
| 2020 |
Clarke, M., Liew, Y. Y., Mathew, S. M., & Marshall, H. S. (2020). Clinical Severity of Gastroenteritis in Children Hospitalized With Rotavirus Infection Before and Post Introduction of a National Rotavirus Vaccination Program in Australia. The Pediatric infectious disease journal, 39(9), e289-e290.
DOI WoS1 Europe PMC1 |
| 2020 |
Marshall, H. S., Koehler, A. P., Wang, B., A'Houre, M., Gold, M., Quinn, H., . . . Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922.
DOI Scopus17 WoS13 Europe PMC10 |
| 2020 |
Aye, A. M. M., Bai, X., Borrow, R., Bory, S., Carlos, J., Caugant, D. A., . . . Zhu, B. (2020). Meningococcal disease surveillance in the Asia-Pacific region (2020): the Global Meningococcal Initiative.. J Infect, 81(5), 698-711.
DOI Scopus68 WoS57 Europe PMC49 |
| 2020 |
Madhi, S. A., Polack, F. P., Piedra, P. A., Munoz, F. M., Trenholme, A. A., Simões, E. A. F., . . . Fries, L. F. (2020). Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. The New England journal of medicine, 383(5), 426-439.
DOI Scopus330 WoS293 Europe PMC301 |
| 2020 |
Marshall, H., & Wood, N. (2020). The potential for improved protection against pertussis. The Lancet Infectious Diseases, 20(11), 1220-1222.
DOI Scopus3 WoS1 Europe PMC1 |
| 2020 |
Marshall, H. S., & Maiden, M. C. J. (2020). The impact of a meningococcal protein-based serogroup B vaccine on serogroup W invasive disease in children.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(7), E1669-E1672.
DOI Scopus4 Europe PMC2 |
| 2020 |
Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Dekker, G. A., & Marshall, H. S. (2020). Safety and protective effects of maternal influenza vaccination on pregnancy and birth outcomes: A prospective cohort study. EClinicalMedicine, 26, 1-9.
DOI Scopus26 WoS21 Europe PMC19 |
| 2020 |
Marshall, H. S., Lally, N., Flood, L., & Phillips, P. (2020). First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia. Medical Journal of Australia, 212(2), 89-93.
DOI Scopus19 WoS20 Europe PMC16 |
| 2020 |
Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., MacLennan, J. M., . . . Richmond, P. (2020). Meningococcal B vaccine and meningococcal carriage in adolescents in Australia. The New England Journal of Medicine, 382(4), 318-327.
DOI Scopus163 WoS143 Europe PMC117 |
| 2020 |
Tuckerman, J., Marshall, H., Snape, M., Collins, J., Straube, S., & Chambers, A. G. (2020). Interventions for increasing the uptake of immunisation in healthcare workers. Cochrane Database of Systematic Reviews, 2020(1).
DOI Scopus1 |
| 2020 |
Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L., Leemaqz, S., Dalton, J., . . . Marshall, H. S. (2020). Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study.. Vaccine, 38(17), 3358-3368.
DOI Scopus20 WoS20 Europe PMC19 |
| 2020 |
Thielemans, E., Oliver, J., McMinn, A., Baker, C., Britton, P. N., Clark, J., . . . Steer, A. C. (2020). Clinical description and outcomes of Australian children with invasive group A streptococcal disease. Pediatric Infectious Disease Journal, 39(5), 379-384.
DOI Scopus12 WoS10 Europe PMC10 |
| 2020 |
Blyth, C. C., Cheng, A. C., Crawford, N. W., Clark, J. E., Buttery, J. P., Marshall, H. S., . . . Macartney, K. K. (2020). The impact of new universal child influenza programs in Australia: vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018. Vaccine, 38(13), 2779-2787.
DOI Scopus26 WoS24 Europe PMC20 |
| 2020 |
Menzies, R., Heron, L., Lampard, J., McMillan, M., Joseph, T., Chan, J., . . . Marshall, H. (2020). A randomised controlled trial of SMS messaging and calendar reminders to improve vaccination timeliness in infants. Vaccine, 38(15), 3137-3142.
DOI Scopus16 WoS18 Europe PMC17 |
| 2020 |
Pearce, J., Peters, M., May, N., Marshall, H., Hein, C., & Grantham, H. (2020). Care of the patient with invasive meningococcal disease by prehospital emergency medical service clinicians: a scoping review. BMJ Open, 10(2), e033447-1-e033447-11.
DOI Scopus4 WoS4 Europe PMC5 |
| 2020 |
Wnukowski-Mtonga, P., Jayasinghe, S., Chiu, C., Macartney, K., Brotherton, J., Donovan, B., . . . Marshall, H. (2020). Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Communicable diseases intelligence (2018), 44, 12 pages.
DOI Scopus9 WoS9 Europe PMC7 |
| 2020 |
Tuckerman, J., Crawford, N. W., & Marshall, H. S. (2020). Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination. PLoS One, 15(4), e0230425.
DOI Scopus16 WoS16 Europe PMC15 |
| 2020 |
Kaufman, J., Attwell, K., Tuckerman, J., O'Sullivan, J., Omer, S. B., Leask, J., . . . Danchin, M. (2020). Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study. Vaccine, 38(24), 4024-4031.
DOI Scopus28 WoS28 Europe PMC22 |
| 2020 |
Tuckerman, J., Crawford, N. W., & Marshall, H. S. (2020). Seasonal influenza vaccination for children with special risk medical conditions: Does policy meet practice?. J Paediatr Child Health, 56(9), 1388-1395.
DOI Scopus6 WoS6 Europe PMC5 |
| 2020 |
Britton, P. N., Dale, R. C., Blyth, C. C., Clark, J. E., Crawford, N., Marshall, H., . . . Jones, C. A. (2020). Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study. Clinical Infectious Diseases, 70(12), 2517-2526.
DOI Scopus70 WoS58 Europe PMC46 |
| 2020 |
Marshall, H. (2020). A nurse's view of Project Lazarus. BMJ MILITARY HEALTH, 166(3), 201.
DOI |
| 2019 |
Marshall, H. (2019). Reflections of a broken world. NEW SCIENTIST, 243(3241), 32.
DOI |
| 2019 |
Marshall, H. (2019). The science fiction column. NEW SCIENTIST, 243(3237), 30.
DOI |
| 2019 |
Marshall, H. (2019). Experimental words. NEW SCIENTIST, 242(3233), 32. |
| 2019 |
Marshall, H. S., & Plotkin, S. (2019). The changing epidemiology of mumps in a high vaccination era (vol 19, pg 118, 2018). LANCET INFECTIOUS DISEASES, 19(2), E39. |
| 2019 |
Marshall, H. S., Baber, J., Richmond, P., Nissen, M., Shakib, S., Kreiswirth, B. N., . . . Anderson, A. S. (2019). S. aureus Colonization in Healthy Australian Adults Receiving an Investigational S. aureus 3-antigen Vaccine.. The Journal of infection, 79(6), 582-592.
DOI Scopus6 WoS6 Europe PMC5 |
| 2019 |
Wang, B., Hajiali Afzali, H., Giles, L., & Marshall, H. (2019). Lifetime costs of invasive meningococcal disease: a Markov model approach. Vaccine, 37(46), 6885-6893.
DOI Scopus8 WoS6 Europe PMC8 |
| 2019 |
Wooldridge, A. L., McMillan, M., Kaur, M., Giles, L. C., Marshall, H. S., & Gatford, K. L. (2019). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review. Journal of Allergy and Clinical Immunology, 144(6), 1703-1713.
DOI Scopus19 WoS18 Europe PMC18 |
| 2019 |
MacIntyre, C. R., Shaw, P. J., Mackie, F. E., Boros, C., Marshall, H., Seale, H., . . . Stormon, M. (2019). Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine, 37(37), 5630-5636.
DOI Scopus15 WoS12 Europe PMC11 |
| 2019 |
Tuckerman, J., Misan, S., Crawford, N. W., & Marshall, H. S. (2019). Influenza in Children With Special Risk Medical Conditions: A Systematic Review and Meta-analysis. The Pediatric Infectious Disease Journal, 38(9), 912-919.
DOI Scopus22 WoS21 Europe PMC18 |
| 2019 |
Carlson, S. J., Scanlan, C., Marshall, H. S., Blyth, C. C., Macartney, K., & Leask, J. (2019). Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia. Vaccine, 37(40), 5994-6001.
DOI Scopus17 WoS17 Europe PMC14 |
| 2019 |
McMillan, M., Walters, L., Mark, T., Lawrence, A., Leong, L., Sullivan, T., . . . Marshall, H. (2019). B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia. Human Vaccines and Immunotherapeutics, 15(4), 987-994.
DOI Scopus31 WoS28 Europe PMC25 |
| 2019 |
Quinn, H. E., Gidding, H. F., Marshall, H. S., Booy, R., Elliott, E. J., Richmond, P., . . . Macartney, K. K. (2019). Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. Journal of Infection, 78(3), 220-225.
DOI Scopus32 WoS34 Europe PMC27 |
| 2019 |
Tuckerman, J., Crawford, N. W., Lynch, J., & Marshall, H. S. (2019). Are children with special risk medical conditions receiving influenza vaccination? Validity of parental and provider report, and to a National Immunisation Register. Human Vaccines and Immunotherapeutics, 15(4), 951-958.
DOI Scopus4 WoS5 Europe PMC4 |
| 2019 |
Nolan, T., Santolaya, M. E., de Looze, F., Marshall, H., Richmond, P., Henein, S., . . . O'Ryan, M. (2019). Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine. Vaccine, 37(9), 1209-1218.
DOI Scopus47 WoS39 Europe PMC34 |
| 2019 |
McRae, J. E., Quinn, H. E., Saravanos, G. L., McMinn, A., Britton, P. N., Wood, N., . . . Macartney, K. (2019). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions. Communicable diseases intelligence (2018), 43, 15 pages.
DOI Scopus9 WoS16 Europe PMC12 |
| 2019 |
Rahaman, M. R., Milazzo, A., Marshall, H., & Bi, P. (2019). Is a One Health Approach Utilized for Q Fever Control? A Comprehensive Literature Review.. International journal of environmental research and public health, 16(5), 22 pages.
DOI Scopus36 WoS34 Europe PMC29 |
| 2019 |
Goh, A. E. N., Choi, E. H., Chokephaibulkit, K., Choudhury, J., Kuter, B., Lee, P. I., . . . Wolfson, L. J. (2019). Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Review of Vaccines, 18(5), 475-493.
DOI Scopus35 WoS28 Europe PMC24 |
| 2019 |
Mohammed, H., McMillan, M., Roberts, C. T., & Marshall, H. S. (2019). A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.. PloS one, 14(3), 0214538.
DOI Scopus39 WoS36 Europe PMC30 |
| 2019 |
Wang, B., Santoreneos, R., Giles, L., Haji Ali Afzali, H., & Marshall, H. (2019). Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine, 37(21), 2768-2782.
DOI Scopus181 WoS162 Europe PMC142 |
| 2019 |
Marshall, H., McMillan, M., Koehler, A., Lawrence, A., MacLennan, J., Maiden, M., . . . Vadivelu, K. (2019). B part of it school leaver protocol: An observational repeat cross-sectional study to assess the impact of a meningococcal serogroup b (4cmenb) vaccine programme on carriage of neisseria meningitidis. BMJ Open, 9(5), 1-7.
DOI Scopus8 WoS7 Europe PMC3 |
| 2019 |
Nolan, T., Booy, R., Marshall, H. S., Richmond, P., Nissen, M., Ziegler, J. B., . . . Van der Wielen, M. (2019). Immunogenicity and safety of a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine 6 years after MenC priming as toddlers. The Pediatric Infectious Disease Journal, 38(6), 643-650.
DOI Scopus8 WoS6 Europe PMC6 |
| 2019 |
Marshall, H. S., & Amirthalingam, G. (2019). Protecting pregnant women and their newborn from life-threatening infections. Medical Journal of Australia, 210(10), 445-446.
DOI |
| 2019 |
Marshall, H., McMillan, M., Wang, B., Booy, R., Afzali, H., Buttery, J., . . . Barton, B. (2019). AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.. BMJ Open, 9(12), e032583.
DOI Scopus4 WoS4 Europe PMC3 |
| 2019 |
Oliver, J., Thielemans, E., McMinn, A., Baker, C., Britton, P. N., Clark, J. E., . . . Crawford, N. W. (2019). Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study. BMC Public Health, 19(1), 1750-1-1750-10.
DOI Scopus31 WoS32 Europe PMC30 |
| 2019 |
Pearce, J., Peters, M. D. J., May, N., Marshall, H., Hein, C., & Grantham, H. (2019). Care of the patient with invasive meningococcal disease by emergency medical service clinicians: A scoping review protocol. Australasian Journal of Paramedicine, 16, 1-7.
DOI Scopus1 |
| 2019 |
Marshall, H., Clarke, M., Heath, C., Quinn, H., Richmond, P., Crawford, N., . . . Macartney, K. (2019). Severe and complicated varicella and associated genotypes 10 years after introduction of a one-dose varicella vaccine program. Journal of Infectious Diseases, 219(3), 391-399.
DOI Scopus8 WoS8 Europe PMC6 |
| 2019 |
Butler, J., Gunnarsson, R., Traves, A., & Marshall, H. (2019). Severe respiratory syncytial virus infection in hospitalized children less than 3 years of age in a temperate and tropical climate. Pediatric Infectious Disease Journal, 38(1), 6-11.
DOI Scopus14 WoS10 Europe PMC13 |
| 2019 |
Blyth, C. C., Macartney, K. K., McRae, J., Clark, J. E., Marshall, H. S., Buttery, J., . . . Influenza Complications Alert Network (FluCAN) Collaboration. (2019). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: results from the PAEDS-FluCAN Collaboration. Clinical Infectious Diseases, 68(6), 940-948.
DOI Scopus46 WoS49 Europe PMC42 |
| 2019 |
McHugh, L., Marshall, H. S., Perrett, K. P., Nolan, T., Wood, N., Lambert, S. B., . . . Andrews, R. M. (2019). The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the FluMum study. Clinical Infectious Diseases, 68(3), 402-408.
DOI Scopus28 WoS22 Europe PMC22 |
| 2018 |
Wood, N., Nolan, T., & Marshall, H. (2018). Immunogenicity and safety of monovalent acellular pertussis vaccine at birth: a randomized clinical trial. Clinical Infectious Diseases, 172(11), 1045-1052.
DOI Scopus37 WoS31 Europe PMC26 |
| 2018 |
Lynn, M., Tumes, D., Choo, J., Sribnaia, A., Blake, S., Leong, L., . . . Lynn, D. (2018). Early-life antibiotic-driven dysbiosis in mice leads to impaired antibody responses and enhanced T cell cytokine recall responses to vaccination. Cell Host and Microbe. |
| 2018 |
Cutland, C., Nolan, T., Halperin, S., Kurugol, Z., Ahmed, K., Perrett, K., . . . Van Der Wielen, M. (2018). Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. Vaccine, 36(14), 1908-1916.
DOI Scopus24 WoS19 Europe PMC13 |
| 2018 |
Tuckerman, J., Misan, S., Salih, S., Joseph Xavier, B., Crawford, N., Lynch, J., & Marshall, H. (2018). Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions. Vaccine, 36(52), 8138-8147.
DOI Scopus22 WoS23 Europe PMC18 |
| 2018 |
Patel, C., Brotherton, J. M. L., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., & Marshall, H. (2018). The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?. Eurosurveillance, 23(41), 30-40.
DOI Scopus244 WoS222 Europe PMC177 |
| 2018 |
Marshall, H. S., & Plotkin, S. (2018). The changing epidemiology of mumps in a high vaccination era. The Lancet Infectious Diseases, 19(2), 118-119.
DOI Scopus29 WoS25 Europe PMC17 |
| 2018 |
Blyth, C., Macartney, K., McRae, J., Clark, J. E., Marshall, H. S., Buttery, J., . . . Paediatric Active Enhanced Disease Surveillance (PAEDS). (2018). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017. Clinical Infectious Diseases, 68(6), 940-948.
DOI |
| 2018 |
Bedford, H., Attwell, K., Danchin, M., Marshall, H., Corben, P., & Leask, J. (2018). Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology. Vaccine, 36(44), 6556-6558.
DOI Scopus250 WoS207 Europe PMC197 |
| 2018 |
Lynn, M., Tumes, D., Choo, J., Sribnaia, A., Blake, S., Leong, L., . . . Lynn, D. (2018). Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice. Cell Host and Microbe, 23(5), 653-660.
DOI Scopus165 WoS148 Europe PMC140 |
| 2018 |
Mohammed, H., Clarke, M., Koehler, A., Watson, M., & Marshall, H. (2018). Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia. PLoS ONE, 13(6), e0197867-1-e0197867-14.
DOI Scopus65 WoS62 Europe PMC45 |
| 2018 |
Wang, B., Santoreneos, R., Afzali, H., Giles, L., & Marshall, H. (2018). Costs of invasive meningococcal disease: a global systematic review. PharmacoEconomics, 36(10), 1201-1222.
DOI Scopus28 WoS24 Europe PMC23 |
| 2018 |
Marshall, H. S., McMillan, M., Koehler, A., Lawrence, A., Maclennan, J. M., Maiden, M. C. J., . . . Vadivelu, K. (2018). B Part of It protocol: A cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open, 8(7), 9 pages.
DOI Scopus32 WoS25 Europe PMC24 |
| 2018 |
Marshall, H. S., Vesikari, T., Richmond, P. C., Szenborn, L., Beeslaar, J., Maguire, J. D., . . . Investigators, B. 1. 9. 7. 1. 0. 3. 5. S. (2018). A Phase 2 Study of the Immunogenicity, Safety, and Tolerability of MenB-FHbp, a Bivalent Meningococcal B Vaccine, in Healthy Toddlers. |
| 2017 |
Marshall, H. (2017). The Medieval Manuscript Book: Cultural Approaches.. SPECULUM-A JOURNAL OF MEDIEVAL STUDIES, 92(2), 539-540.
DOI |
| 2017 |
Fell, D., Azziz-Baumgartner, E., Baker, M., Batra, M., Beauté, J., Beutels, P., . . . Ortiz, J. (2017). Influenza epidemiology and immunization during pregnancy: final report of a World Health Organization working group. Vaccine, 35(43), 5738-5750.
DOI Scopus85 WoS81 Europe PMC69 |
| 2017 |
DeSilva, M., Munoz, F. M., Sell, E., Marshall, H., Tse Kawai, A., Kachikis, A., . . . Bardají, A. (2017). Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. Vaccine, 35(48), 6472-6482.
DOI Scopus46 WoS51 Europe PMC45 |
| 2017 |
Sweet, L., Keech, C., Klein, N., Marshall, H., Tagbo, B., Quine, D., . . . Muñoz, F. (2017). Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine, 35(48), 6506-6517.
DOI Scopus48 WoS40 Europe PMC36 |
| 2017 |
Marshall, H., Richmond, P., Beeslaar, J., Jiang, Q., Jansen, K., Garcés-Sánchez, M., . . . Perez, J. (2017). Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases, 17(1), 58-67.
DOI Scopus37 WoS30 Europe PMC23 |
| 2017 |
McMillan, M., Clarke, M., Parrella, A., Fell, D., Amirthalingam, G., & Marshall, H. (2017). Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy a systematic review. Obstetrics and Gynecology, 129(3), 560-573.
DOI Scopus90 WoS71 Europe PMC60 |
| 2017 |
McHugh, L., Andrews, R. M., Lambert, S. B., Viney, K. A., Wood, N., Perrett, K. P., . . . O'Grady, K. A. F. (2017). Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: the FluMum study. Vaccine, 35(10), 1403-1409.
DOI Scopus25 WoS23 Europe PMC19 |
| 2017 |
Forster, A., Mahendran, K., Davies, C., Stoney, T., Marshall, H., McGeechan, K., . . . Skinner, S. (2017). Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety. Public Health, 147, 77-83.
DOI Scopus35 WoS29 Europe PMC25 |
| 2017 |
Davies, C., Skinner, S., Stoney, T., Marshall, H., Collins, J., Jones, J., . . . Zimet, G. (2017). 'Is it like one of those infectious kind of things?' The importance of educating young people about HPV and HPV vaccination at school. Sex Education, 17(3), 256-275.
DOI Scopus47 WoS39 |
| 2017 |
Britton, P., Blyth, C., Macartney, K., Dale, R., Li-Kim-Moy, J., Khandaker, G., . . . Jones, C. (2017). The spectrum and burden of influenza-associated neurological disease in children: combined encephalitis and influenza sentinel site surveillance from Australia 2013-2015. Clinical Infectious Diseases, 65(4), 653-660.
DOI Scopus78 WoS73 |
| 2017 |
Katz, M., Gessner, B., Johnson, J., Skidmore, B., Knight, M., Bhat, N., . . . Fell, D. (2017). Incidence of influenza virus infection among pregnant women: A systematic review. BMC Pregnancy and Childbirth, 17(1), 12 pages.
DOI Scopus50 WoS42 Europe PMC43 |
| 2017 |
Costa-Pinto, J., Willaby, H., Leask, J., Wood, N., Marshall, H., & Danchin, M. (2017). Vaccine discussions with parents: The experience of Australian paediatricians. Journal of Paediatrics and Child Health, 53(9), 855-861.
DOI Scopus13 WoS12 Europe PMC12 |
| 2017 |
Katz, M. A., Gessner, B. D., Johnson, J., Skidmore, B., Knight, M., Bhat, N., . . . Fell, D. B. (2017). Erratum: Incidence of influenza virus infection among pregnant women: A systematic review [BMC Pregnancy and Childbirth., 17, 1, (2017) (155)] DOI:10.1186/s12884-017-1333-5. BMC Pregnancy and Childbirth, 17(1), 1 page.
DOI Scopus2 WoS2 Europe PMC1 |
| 2017 |
Britton, P., Dale, R., Blyth, C., Macartney, K., Crawford, N., Marshall, H., . . . Jones, C. (2017). Influenza-associated encephalitis/encephalopathy identified by the Australian Childhood Encephalitis study 2013-2015. Pediatric Infectious Disease Journal, 36(11), 1021-1026.
DOI Scopus57 WoS58 Europe PMC43 |
| 2017 |
Wang, B., Chen, G., Ratcliffe, J., Afzali, H., Giles, L., & Marshall, H. (2017). Adolescent values for immunisation programs in Australia: a discrete choice experiment. PLoS ONE, 12(7), e0181073-1-e0181073-14.
DOI Scopus20 WoS19 Europe PMC20 |
| 2017 |
Danchin, M., Costa-Pinto, J., Atwell, K., Willaby, H., Wiley, K., Hoq, M., . . . Marshall, H. (2017). Vaccine decision-making begins in pregnancy: correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. Vaccine, 36(44), 6473-6479.
DOI Scopus137 WoS119 Europe PMC104 |
| 2017 |
Britton, P. N., Blyth, C. C., Macartney, K., Dale, R. C., Li-Kim-Moy, J., Khandaker, G., . . . Australian Childhood Encephalitis (ACE) Study Investigators, Influenza Complications Alert Network (FluCAN) Investigators, and Paediatric Active Enhanced Disease Surveillance (PAEDS) Network. (2017). The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(4), 653-660.
DOI Europe PMC67 |
| 2017 |
Tooher, R., collins, J., Braunack-Mayer, A., burgess, T., Skinner, S., O'keefe, M., . . . Marshall, H. (2017). Intersectoral collaboration to implement school-based health programmes: Australian perspectives. Health Promotion International, 32(2), 312-321.
DOI Scopus39 WoS42 Europe PMC28 |
| 2017 |
Fell, D., Savitz, D., Kramer, M., Gessner, B., Katz, M., Knight, M., . . . Ortiz, J. (2017). Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG: An International Journal of Obstetrics and Gynaecology, 124(1), 48-59.
DOI Scopus129 WoS118 Europe PMC110 |
| 2016 |
Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., . . . Lan, R. (2016). Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. Vaccine, 34(34), 3967-3971.
DOI Scopus30 WoS32 Europe PMC27 |
| 2016 |
Lakhan, N., Clarke, M., Mathew, S., & Marshall, H. (2016). Retrospective review of factors associated with severe hospitalised community-acquired influenza in a tertiary paediatric hospital in South Australia. Influenza and other Respiratory Viruses, 10(6), 479-485.
DOI Scopus8 WoS8 Europe PMC9 |
| 2016 |
MacIntyre, C., Shaw, P., Mackie, F., Boros, C., Marshall, H., Barnes, M., . . . Stormon, M. (2016). Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine, 34(36), 4343-4350.
DOI Scopus29 WoS22 Europe PMC19 |
| 2016 |
DeSilva, M., Munoz, F. M., Mcmillan, M., Kawai, A. T., Marshall, H., Macartney, K. K., . . . Kharbanda, E. O. (2016). Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 34(49), 6015-6026.
DOI Scopus104 WoS90 Europe PMC78 |
| 2016 |
Marshall, H., Nissen, M., Richmond, P., Shakib, S., Jiang, Q., Cooper, D., . . . Girgenti, D. (2016). Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study. Journal of Infection, 73(5), 437-454.
DOI Scopus11 WoS11 Europe PMC7 |
| 2016 |
Mcbride, W., Abhayaratna, W., Barr, I., Booy, R., Carapetis, J., Carson, S., . . . Greenberg, M. (2016). Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial. Vaccine, 34(41), 4991-4997.
DOI Scopus12 WoS11 Europe PMC12 |
| 2016 |
Cooper, S., Davies, C., McBride, K., Blades, J., Stoney, T., Marshall, H., & Skinner, S. (2016). Development of a human papillomavirus vaccination intervention for Australian adolescents. Health Education Journal, 75(5), 610-620.
DOI Scopus14 WoS14 |
| 2016 |
Wang, B., Giles, L., Afzali, H., Clarke, M., Ratcliffe, J., Chen, G., & Marshall, H. (2016). Adolescent confidence in immunisation: assessing and comparing attitudes of adolescents and adults. Vaccine, 34(46), 5595-5603.
DOI Scopus15 WoS15 Europe PMC12 |
| 2016 |
Safarchi, A., Octavia, S., Wu, S., Kaur, S., Sintchenko, V., Gilbert, G., . . . Lan, R. (2016). Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. Journal of Infection, 72(4), 468-477.
DOI Scopus36 WoS35 Europe PMC35 |
| 2016 |
Tuckerman, J., Thomas, N., & Marshall, H. (2016). Should professionals caring for children be vaccinated? Community perspectives on health care and child care worker immunisation. Vaccine, 34(14), 1726-1732.
DOI Scopus6 WoS4 Europe PMC4 |
| 2016 |
Marshall, H., McMillan, M., Andrews, R., Macartney, K., & Edwards, K. (2016). Vaccines in pregnancy: the dual benefit for pregnant women and infants. Human Vaccines and Immunotherapeutics, 12(4), 848-856.
DOI Scopus74 WoS69 Europe PMC57 |
| 2016 |
Parrella, A., Braunack-Mayer, A., Collins, J., Clarke, M., Tooher, R., Ratcliffe, J., & Marshall, H. (2016). Prioritizing government funding of adolescent vaccinations: recommendations from young people on a citizens' jury. Vaccine, 34(31), 3592-3597.
DOI Scopus10 WoS7 Europe PMC6 |
| 2016 |
Clarke, M., McIntyre, P., Blyth, C., Wood, N., Octavia, S., Sintchenko, V., . . . Marshall, H. (2016). The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. Journal of Infection, 72(2), 171-178.
DOI Scopus36 WoS34 Europe PMC32 |
| 2016 |
Burgess, T., Braunack-Mayer, A., Tooher, R., Collins, J., O'Keefe, M., Skinner, R., . . . Marshall, H. (2016). Optimizing intersectoral collaboration between health and education: the Health Bridges study. Journal of Public Health, 38(4), e430-e437.
DOI Scopus22 WoS17 Europe PMC11 |
| 2016 |
Marshall, H., Chen, G., Clarke, M., & Ratcliffe, J. (2016). Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a Discrete Choice Experiment. Vaccine, 34(5), 671-677.
DOI Scopus53 WoS51 Europe PMC49 |
| 2016 |
Wooldridge, A. L., McMillan, M., Marshall, H. S., & Gatford, K. L. (2016). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 14(11), 11-20.
DOI Scopus4 Europe PMC1 |
| 2016 |
Marshall, H., Wang, B., Wesselingh, S., Snape, M., & Pollard, A. J. (2016). Control of invasive meningococcal disease: Is it achievable?. International Journal of Evidence Based Healthcare, 14(1), 3-12.
DOI Scopus10 WoS9 Europe PMC6 |
| 2016 |
Tuckerman, J., Shrestha, L., Collins, J., & Marshall, H. (2016). Understanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in Australia. Human Vaccines and Immunotherapeutics, 12(7), 1749-1756.
DOI Scopus11 WoS10 Europe PMC7 |
| 2016 |
Marshall, H., & Taylor, K. (2016). Up the Value Chain: Transition from Law Librarian to Research Analyst. LEGAL INFORMATION MANAGEMENT, 16(4), 207-211.
DOI |
| 2015 |
Mao, J., & Bao, S. (2015). Comparative studies on buckling behaviors of T joint and pipe by varying geometric parameters and analysis methods. INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES, 90(4), 113-121.
DOI Scopus1 WoS7 |
| 2015 |
Burgess, T., Braunack-Mayer, A., Tooher, R., Collins, J., O'Keefe, M., Skinner, R., . . . Marshall, H. (2015). Optimizing intersectoral collaboration between health and education: the Health Bridges study.. Journal of public health (Oxford, England).
DOI |
| 2015 |
La Vincente, S., Mielnik, D., Jenkins, K., Bingwor, F., Volavola, L., Marshall, H., . . . Mulholland, E. (2015). Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents. BMC Public Health, 15(1), 1257-1-1257-11.
DOI Scopus24 WoS19 Europe PMC21 |
| 2015 |
Pearce, A., Marshall, H., Bedford, H., & Lynch, J. (2015). Barriers to childhood immunisation: findings from the Longitudinal Study of Australian Children. Vaccine, 33(29), 3377-3383.
DOI Scopus73 WoS63 Europe PMC51 |
| 2015 |
Braunack-Mayer, A., Skinner, S., Collins, J., Tooher, R., Proeve, C., O'Keefe, M., . . . Marshall, H. (2015). Ethical challenges in school-based immunization programs for adolescents: a qualitative study. American Journal of Public Health, 105(7), 1399-1403.
DOI Scopus17 WoS15 Europe PMC14 |
| 2015 |
Tuckerman, J., Collins, J., & Marshall, H. (2015). Factors affecting uptake of recommended immunizations among health care workers in South Australia. Human Vaccines and Immunotherapeutics, 11(3), 704-712.
DOI Scopus33 WoS31 Europe PMC28 |
| 2015 |
Nissen, M., Marshall, H., Richmond, P., Shakib, S., Jiang, Q., Cooper, D., . . . Girgenti, D. (2015). A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. Vaccine, 33(15), 1846-1854.
DOI Scopus53 WoS53 Europe PMC45 |
| 2015 |
McMillan, M., Porritt, K., Kralik, D., Costi, L., & Marshall, H. (2015). Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine, 33(18), 2108-2117.
DOI Scopus133 WoS123 Europe PMC107 |
| 2015 |
Wong, C., Thomas, N., Clarke, M., Boros, C., Tuckerman, J., & Marshall, H. (2015). Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunzations. Human Vaccines and Immunotherapeutics, 11(5), 1165-1172.
DOI Scopus38 WoS36 Europe PMC27 |
| 2015 |
Marshall, H., Richmond, P., Nissen, M., Lambert, S., Booy, R., Reynolds, G., . . . Scully, I. (2015). Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in Australia. Pediatric Infectious Disease Journal, 34(8), 831-838.
DOI Scopus16 WoS15 Europe PMC13 |
| 2015 |
Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., . . . Lan, R. (2015). Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine, 33(46), 6277-6281.
DOI Scopus83 WoS83 Europe PMC77 |
| 2015 |
Clarke, M., Thomas, N., Giles, L., & Marshall, H. (2015). Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults. Vaccine, 33(51), 7337-7343.
DOI Scopus7 WoS7 Europe PMC7 |
| 2015 |
Perrett, K., McVernon, J., Richmond, P., Marshall, H., Nissen, M., August, A., . . . Nolan, T. (2015). Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study. Vaccine, 33(39), 5217-5224.
DOI Scopus41 WoS37 Europe PMC35 |
| 2015 |
Skinner, S. R., Davies, C., Cooper, S., Stoney, T., Marshall, H., Jones, J., . . . McGeechan, K. (2015). HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents. BMC Public Health, 15(1), 896-1-896-9.
DOI Scopus31 WoS26 Europe PMC18 |
| 2015 |
Booy, R., Nolan, T., Reynolds, G., Richmond, P., Nissen, M., Marshall, H., . . . Miller, J. (2015). Five-year antibody persistence and safety after a single dose of combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in Haemophilus influenzae Type B-primed toddlers. Pediatric Infectious Disease Journal, 34(12), 1379-1384.
DOI Scopus4 WoS4 Europe PMC3 |
| 2015 |
Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., . . . Wood, N. (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417.
DOI Scopus28 WoS23 Europe PMC18 |
| 2015 |
Marshall, H., Clarke, M., Rasiah, K., Richmond, P., Buttery, J., Reynolds, G., . . . Mcintyre, P. (2015). Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatric Infectious Disease Journal, 34(4), 339-345.
DOI Scopus65 WoS61 Europe PMC51 |
| 2014 |
Nolan, T., Izurieta, P., Lee, B., Chan, P., Marshall, H., Booy, R., . . . Vaughn, D. (2014). Heterologous prime-boost vaccination using an ASO3B-adjuvanted influenza A(H5N1) vaccine in infants and children <3 years of age. Journal of Infectious Diseases, 210(11), 1800-1810.
DOI Scopus18 WoS17 Europe PMC17 |
| 2014 |
McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2014). Influenza vaccination during pregnancy: A systematic review of effectiveness and safety. JBI Database of Systematic Reviews and Implementation Reports, 12(6), 281-381.
DOI Scopus4 |
| 2014 |
Wang, B., Clarke, M., Thomas, N., Howell, S., Afzali, H., & Marshall, H. (2014). The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children. Pediatric Infectious Disease Journal, 33(3), 316-318.
DOI Scopus23 WoS25 Europe PMC20 |
| 2014 |
O'Grady, K. A. F., McHugh, L., Nolan, T., Richmond, P., Wood, N., Marshall, H. S., . . . Andrews, R. M. (2014). FluMum: a prospective cohort study of mother-infant pairs assessing the effectiveness of maternal influenza vaccination in revention of influenza in early infancy. BMJ Open, 4(6), e005676-1-e005676-6.
DOI Scopus12 WoS14 Europe PMC10 |
| 2014 |
Taylor, K., Stocks, N., & Marshall, H. (2014). The missing link: family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines. Vaccine, 32(33), 4214-4219.
DOI Scopus9 WoS9 Europe PMC8 |
| 2014 |
Khandaker, G., Zurynski, Y., Ridley, G., Buttery, J., Marshall, H., Richmond, P., . . . Elliott, E. (2014). Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza and Other Respiratory Viruses, 8(6), 636-645.
DOI Scopus25 WoS16 Europe PMC20 |
| 2014 |
Collins, J., Alona, I., Tooher, R., & Marshall, H. (2014). Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated. Human Vaccines and Immunotherapeutics, 10(10), 2922-2929.
DOI Scopus40 WoS35 Europe PMC37 |
| 2014 |
Wood, N., Marshall, H., White, O., Holt, P., & McIntyre, P. (2014). Antibody and cell-mediated immunity to pertussis 4 years after monovalent acellular pertussis vaccine at birth. Pediatric Infectious Disease Journal, 33(5), 511-517.
DOI Scopus12 WoS12 Europe PMC9 |
| 2014 |
Wang, B., Haji Ali Afzali, H., & Marshall, H. (2014). The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine, 32(37), 4791-4798.
DOI Scopus33 WoS26 Europe PMC27 |
| 2014 |
Webb, H., Street, J., & Marshall, H. (2014). Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations. Human Vaccines & Immunotherapeutics, 10(4), 1114-1121.
DOI Scopus33 WoS30 Europe PMC30 |
| 2014 |
Lam, C., & Marshall, H. (2014). Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerging Infectious Diseases, 20(4), 626-633.
DOI Scopus166 WoS158 Europe PMC135 |
| 2014 |
Marshall, H., Proeve, C., Collins, J., Tooher, R., O'Keefe, M., Burgess, T., . . . Braunack-Mayer, A. (2014). Eliciting youth and adult recommendations through citizens' juries to improve school based adolescent immunisation programs. Vaccine, 32(21), 2434-2440.
DOI Scopus22 WoS20 Europe PMC17 |
| 2014 |
Parrella, A., Gold, M., Braunack-Mayer, A., Baghurst, P., & Marshall, H. (2014). Consumer reporting of adverse events following immunization (AEFI): Identifying predictors of reporting an AEFI. Human Vaccines & Immunotherapeutics, 10(3), 747-754.
DOI Scopus15 WoS13 Europe PMC13 |
| 2014 |
Wang, B., Clarke, M., Hajiali Afzali, H., & Marshall, H. (2014). Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine, 32(18), 2042-2049.
DOI Scopus24 WoS22 Europe PMC21 |
| 2014 |
Marshall, H., Clarke, M., & Sullivan, T. (2014). Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines. Vaccine, 32(3), 338-344.
DOI Scopus31 WoS29 Europe PMC24 |
| 2014 |
Tuckerman, J., Marshall, H., Snape, M., Collins, J., Straube, S., & Chambers, A. G. (2014). Interventions for increasing the uptake of immunisation in healthcare workers. Cochrane Database of Systematic Reviews, 2014(11).
DOI |
| 2014 |
Drowley, M., & Marshall, H. (2014). Developing a framework for managing academic standards, quality and enhancement: addressing concerns and embedding good practice. INDEPENDENT JOURNAL OF TEACHING AND LEARNING, 9, 83-95. |
| 2013 |
Saunders, D., Marshall, H., Cowe, F., Payne, R., & Rogers, A. (2013). Developing higher education in South Wales: The emergence of the Universities Heads of the Valleys Institute. JOURNAL OF ADULT AND CONTINUING EDUCATION, 19(1), 76-100.
DOI WoS2 |
| 2013 |
Drowley, M., & Marshall, H. (2013). National qualifications frameworks: local learning from global experience. QUALITY IN HIGHER EDUCATION, 19(1), 73-89.
DOI WoS3 |
| 2013 |
Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., . . . Liu, S. (2013). International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458.
DOI Scopus92 WoS83 Europe PMC73 |
| 2013 |
Tooher, R., Collins, J., Street, J., Braunack-Mayer, A., & Marshall, H. (2013). Community knowledge, behaviours and attitudes about the 2009 H1N1 influenza pandemic: a systematic review. Influenza and Other Respiratory Viruses, 7(6), 1316-1327.
DOI Scopus63 WoS55 Europe PMC39 |
| 2013 |
Parrella, A., Braunack-Mayer, A., Gold, M., Marshall, H., & Baghurst, P. (2013). Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Services Research, 13(313), 1-12.
DOI Scopus41 WoS40 Europe PMC32 |
| 2013 |
Lambert, S., Chuk, L., Nissen, M., Nolan, T., McVernon, J., Booy, R., . . . Lai, M. (2013). Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents. Influenza and Other Respiratory Viruses, 7(5), 676-685.
DOI Scopus17 WoS16 Europe PMC12 |
| 2013 |
Marshall, H., Clarke, M., Evans, S., Piotto, L., & Gent, R. (2013). Randomized trial using ultrasound to assess intramuscular vaccination at a 60 degrees or 90 degrees needle angle. Vaccine, 31(23), 2647-2652.
DOI Scopus7 WoS7 Europe PMC6 |
| 2013 |
Marshall, H., Collins, J., Sullivan, T., Tooher, R., O'Keefe, M., Skinner, S., . . . Braunack-Mayer, A. (2013). Parental and societal support for adolescent immunization through school based immunization programs. Vaccine, 31(30), 3059-3064.
DOI Scopus15 WoS14 Europe PMC10 |
| 2013 |
Marshall, H., McIntyre, P., Richmond, P., Buttery, J., Royle, J., Gold, M., . . . Booy, R. (2013). Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatric Infectious Disease Journal, 32(5), 530-537.
DOI Scopus38 WoS33 Europe PMC28 |
| 2013 |
Braunack-Mayer, A., Tooher, R., Collins, J., Street, J., & Marshall, H. (2013). Understanding the school community's response to school closures during the H1N1 2009 influenza pandemic. BMC Public Health, 13(1), 1-15.
DOI Scopus119 WoS98 Europe PMC86 |
| 2013 |
Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., & Baghurst, P. (2013). Parental perspectives of vaccine safety and experience of adverse events following immunisation. Vaccine, 31(16), 2067-2074.
DOI Scopus38 WoS34 Europe PMC31 |
| 2013 |
Nissen, M., Marshall, H., Richmond, P., Jiang, Q., Harris, S., Jones, T., . . . Perez, J. (2013). A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatric Infectious Disease Journal, 32(4), 364-371.
DOI Scopus53 WoS48 Europe PMC43 |
| 2013 |
Marshall, H., Richmond, P., Nissen, M., Wouters, A., Baber, J., Jiang, Q., . . . Perez, J. (2013). A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults. Vaccine, 31(12), 1569-1575.
DOI Scopus76 WoS62 Europe PMC51 |
| 2013 |
Booy, R., Richmond, P., Nolan, T., McVernon, J., Marshall, H., Nissen, M., . . . Miller, J. (2013). Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlers. Pediatric Infectious Disease Journal, 32(2), 169-174.
DOI Scopus11 WoS8 Europe PMC5 |
| 2013 |
Clarke, M., Rasiah, K., Copland, J., Watson, M., Koehler, A., Dowling, K., & Marshall, H. (2013). The pertussis epidemic: informing strategies for prevention of severe disease. Epidemiology and Infection, 141(3), 463-471.
DOI Scopus20 WoS20 Europe PMC16 |
| 2012 |
Bryant, K., McVernon, J., Marchant, C., Nolan, T., Marshall, G., Richmond, P., . . . Miller, J. (2012). Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Human Vaccines & Immunotherapeutics, 8(8), 1036-1041.
DOI Scopus10 WoS9 Europe PMC7 |
| 2012 |
Richmond, P., Marshall, H., Nissen, M., Jiang, Q., Jansen, K., Garces-Sanchez, M., . . . Perez, J. (2012). Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases, 12(8), 597-607.
DOI Scopus125 WoS101 Europe PMC93 |
| 2012 |
Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., Watson, M., & Baghurst, P. (2012). Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Human Vaccines & Immunotherapeutics, 8(5), 662-667.
DOI Scopus21 WoS18 Europe PMC16 |
| 2012 |
Kessels, S., Marshall, H., Watson, M., Braunack-Mayer, A., Reuzel, R., & Tooher, R. (2012). Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine, 30(24), 3546-3556.
DOI Scopus393 WoS372 Europe PMC339 |
| 2012 |
Marshall, H., Tooher, R., Collins, J., Mensah, F., Braunack-Mayer, A., Street, J., & Ryan, P. (2012). Awareness, anxiety, compliance: Community perceptions and response to the threat and reality of an influenza pandemic. American Journal of Infection Control, 40(3), 270-272.
DOI Scopus18 WoS15 Europe PMC13 |
| 2012 |
McVernon, J., Nolan, T., Richmond, P., Reynolds, G., Nissen, M., Lambert, S., . . . Rehm, C. (2012). A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers. Pediatric Infectious Disease Journal, 31(1), E15-E23.
DOI Scopus14 WoS12 Europe PMC10 |
| 2012 |
Seale, H., Trung, L., Mackie, F., Kennedy, S., Boros, C., Marshall, H., . . . MacIntyre, C. (2012). A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children. Vaccine, 30(49), 7027-7031.
DOI Scopus10 WoS9 Europe PMC10 |
| 2012 |
Khandaker, G., Zurynski, Y., Buttery, J., Marshall, H., Richmond, P., Dale, R., . . . Booy, R. (2012). Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology, 79(14), 1474-1481.
DOI Scopus73 WoS63 Europe PMC62 |
| 2012 |
Marshall, H., Richmond, P., Nissen, M., Jiang, Q., Anderson, A., Jansen, K., . . . Perez, J. (2012). Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial. Pediatric Infectious Disease Journal, 31(10), 1061-1068.
DOI Scopus60 WoS53 Europe PMC43 |
| 2012 |
Khandaker, G., Rashid, H., Zurynski, Y., Richmond, P., Buttery, J., Marshall, H., . . . Booy, R. (2012). Nosocomial vs community-acquired pandemic influenza A (H1N1) 2009: a nested case-control study. Journal of Hospital Infection, 82(2), 94-100.
DOI Scopus8 WoS8 Europe PMC8 |
| 2012 |
Richmond, P., Nissen, M., Marshall, H., Lambert, S., Roberton, D., Gruber, W., . . . Arora, A. (2012). A bivalent Neisserie meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine, 30(43), 6163-6174.
DOI Scopus48 WoS48 Europe PMC42 |
| 2012 |
Clarke, M., & Marshall, H. (2012). Rotavirus vaccination for prevention of serious acute gastroenteritis and the importance of postlicensure safety monitoring. Journal of Infectious Diseases, 206(1), 3-5.
DOI Scopus1 WoS1 Europe PMC1 |
| 2012 |
McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2012). Influenza vaccination during pregnancy: A systematic review of effectiveness and adverse effects. JBI Database of Systematic Reviews and Implementation Reports, 10(56 Suppl), S216-S226.
DOI Scopus1 Europe PMC8 |
| 2011 |
Clarke, M., Davidson, G., Gold, M., & Marshall, H. (2011). Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine, 29(29-30), 4663-4667.
DOI Scopus54 WoS50 Europe PMC41 |
| 2011 |
Quinn, P., Gold, M., Royle, J., Buttery, J., Richmond, P., McIntyre, P., . . . Marshall, H. (2011). Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine, 29(25), 4230-4237.
DOI Scopus19 WoS20 Europe PMC13 |
| 2011 |
Khandaker, G., Marshall, H., Peadon, E., Zurynski, Y., Burgner, D., Buttery, J., . . . Booy, R. (2011). Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Archives of Disease in Childhood, 96(5), 453-456.
DOI Scopus50 WoS37 Europe PMC30 |
| 2011 |
Booy, R., Richmond, P., Nolan, T., McVernon, J., Marshall, H., Nissen, M., . . . Boutriau, D. (2011). Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age. Pediatric Infectious Disease Journal, 30(4), 340-342.
DOI Scopus13 WoS11 Europe PMC10 |
| 2011 |
Nolan, T., Richmond, P., Marshall, H., McVernon, J., Alexander, K., Mesaros, N., . . . Boutriau, D. (2011). Immunogenicity and safety of an investigational combined haemophilus influenzae Type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine. Pediatric Infectious Disease Journal, 30(3), 190-196.
DOI Scopus29 WoS23 Europe PMC21 |
| 2011 |
Buttery, J. P., Danchin, M. H., Lee, K. J., Carlin, J. B., McIntyre, P. B., Elliott, E. J., . . . Bines, J. E. (2011). Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia. VACCINE, 29(16), 3061-3066.
DOI WoS219 Europe PMC187 |
| 2011 |
Beaumont, J., & Marshall, H. (2011). With Change Comes Challenge: Law Firm Mergers. LEGAL INFORMATION MANAGEMENT, 11(4), 289-293.
DOI WoS1 |
| 2011 |
Marshall, H. (2011). Literature and Heresy in the Age of Chaucer. ENGLISH HISTORICAL REVIEW, 126(519), 418-419.
DOI |
| 2011 |
Charlesworth, S., & Marshall, H. (2011). Sacrificing workers? The curious case of salary sacrificing in non-profit community services in Australia. INTERNATIONAL JOURNAL OF PUBLIC SECTOR MANAGEMENT, 24(7), 673-+.
DOI WoS13 |
| 2010 |
Medina, D. M. R., Valencia, A., de Velasquez, A., Huang, L. -M., Prymula, R., Garcia-Sicilia, J., . . . Dubin, G. (2010). Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls. JOURNAL OF ADOLESCENT HEALTH, 46(5), 414-421.
DOI WoS42 Europe PMC39 |
| 2010 |
Carbonell-Estrany, X., Simoes, E. A. F., Dagan, R., Hall, C. B., Harris, B., Hultquist, M., . . . Losonsky, G. A. (2010). Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial. PEDIATRICS, 125(1), E35-E51.
DOI WoS171 Europe PMC148 |
| 2010 |
White, O., Rowe, J., Richmond, P., Marshall, H., McIntyre, P., Wood, N., & Holt, P. (2010). Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine, 28(14), 2648-2652.
DOI Scopus43 WoS38 Europe PMC35 |
| 2010 |
Marshall, H., Nolan, T., Diez-Domingo, J., Rombo, L., Sokal, E., Mares, J., . . . Jacquet, J. (2010). Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine, 28(27), 4411-4415.
DOI Scopus12 WoS12 Europe PMC8 |
| 2010 |
Wood, N., McIntyre, P., Marshall, H., & Roberton, D. (2010). Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatric Infectious Disease Journal, 29(3), 209-215.
DOI Scopus102 WoS83 Europe PMC67 |
| 2010 |
Nolan, T., McVernon, J., Skeljo, M., Richmond, P., Wadia, U., Lambert, S., . . . Greenberg, M. (2010). Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial. Jama-journal of the American Medical Association, 303(1), 37-46.
DOI Scopus182 WoS159 Europe PMC138 |
| 2010 |
Marshall, H., McIntyre, P., Roberton, D., Dinan, L., & Hardt, K. (2010). Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. International Journal of Infectious Diseases, 14(1), E41-E49.
DOI Scopus5 WoS4 Europe PMC4 |
| 2009 |
Marshall, H., Ryan, P., Roberton, D., & Beilby, J. (2009). Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine. Journal of Paediatrics and Child Health, 45(5), 297-303.
DOI Scopus19 WoS19 Europe PMC16 |
| 2009 |
Gibson, R., Barclay, D., Marshall, H., Moulin, J., Maire, J., & Makrides, M. (2009). Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. British Journal of Nutrition, 101(11), 1706-1713.
DOI Scopus42 WoS41 Europe PMC32 |
| 2009 |
Marshall, H., Ryan, P., Roberton, D., Street, J., & Watson, M. (2009). Pandemic influenza and community preparedness. American Journal of Public Health, 99(SUPPL. 2), S365-S371.
DOI Scopus38 WoS35 Europe PMC26 |
| 2009 |
de Benedictis, F. M., Franceschini, F., Hill, D., Naspitz, C., Simons, F. E. R., Wahn, U., . . . Vogel, M. (2009). The allergic sensitization in infants with atopic eczema from different countries. Allergy European Journal of Allergy and Clinical Immunology, 64(2), 295-303.
DOI Scopus98 Europe PMC63 |
| 2008 |
Marshall, H., Ryan, P., Roberton, D., Street, J., & Watson, M. (2008). Pandemic Influenza Preparedness: is the Community Really Prepared?. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 12, E439.
DOI |
| 2008 |
Grüber, C., Warner, J., Hill, D., Bauchau, V., Warner, J. O., Naspitz, C. K., . . . Abeck, D. (2008). Early atopic disease and early childhood immunization - Is there a link?. Allergy European Journal of Allergy and Clinical Immunology, 63(11), 1464-1472.
DOI Scopus51 WoS41 Europe PMC30 |
| 2008 |
Hill, D. J., Hosking, C. S., de Benedictis, F. M., Oranje, A. P., Diepgen, T. L., Bauchau, V., & EPAAC Study Group. (2008). Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clinical & Experimental Allergy, 38(1), 161-168.
DOI Scopus200 WoS166 Europe PMC113 |
| 2008 |
Nolan, T., Bernstein, D., Block, S., Hilty, M., Keyserling, H., Marchant, C., . . . Mendelman, P. (2008). Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with Measles-Mumps-Rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics, 121(3), 508-516.
DOI Scopus52 WoS28 Europe PMC28 |
| 2008 |
Marshall, H. S., & Isaacs, D. (2008). "I want the one for older women" - Extending the human papillomavirus vaccine population base. Medical Journal of Australia, 189(9), 527.
DOI Europe PMC1 |
| 2007 |
Nolan, T., Lambert, S., Roberton, D., Marshall, H., Richmond, P., Streeton, C., . . . Boutriau, D. (2007). A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine, 25(51), 8487-8499.
DOI Scopus49 WoS45 Europe PMC39 |
| 2007 |
Nolan, T., Lambert, S., Roberton, D., Marshall, H., Richmond, P., & Streeton, C. (2007). DTPa-HBV-IPV vaccine for primary vaccination of infants. Journal of Paediatrics and Child Health, 43(9), 587-592.
DOI Scopus8 WoS7 Europe PMC4 |
| 2007 |
Marshall, H., Ryan, P., Roberton, D., & Baghurst, P. (2007). A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Australian and New Zealand Journal of Public Health, 31(3), 235-242.
DOI Scopus93 WoS91 Europe PMC69 |
| 2007 |
Marshall, H. (2007). Annual favorite. ARCHITECTURAL DIGEST, 64(6), 32. |
| 2006 |
Peadon, E., Burgner, D., Nissen, M., Buttery, J., Zurynski, Y., Elliott, E., . . . Booy, R. (2006). Case for varicella surveillance in Australia. Journal of Paediatrics and Child Health, 42(11), 663-664.
DOI Scopus7 WoS2 Europe PMC6 |
| 2006 |
Hofman, T., Cranswick, N., Kuna, P., Boznanski, A., Latos, T., Gold, M., . . . Szalai, Z. (2006). Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Archives of Disease in Childhood, 91(11), 905-910.
DOI Scopus33 WoS29 Europe PMC23 |
| 2006 |
Marshall, H., Gold, M., Gent, R., Quinn, P., Piotto, L., Clarke, M., & Roberton, D. (2006). Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children. Pediatrics, 118(4), 1501-1509.
DOI Scopus22 WoS20 Europe PMC16 |
| 2006 |
Marshall, H., Nolan, T., Roberton, D., Richmond, P., Lambert, S., Jacquet, J., & Schuerman, L. (2006). A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years. Vaccine, 24(35-36), 6120-6128.
DOI Scopus23 WoS15 Europe PMC14 |
| 2006 |
Jacquet, J., Begue, P., Grimprel, E., Reinert, P., Sandbu, S., Silfverdal, S., . . . Schuerman, L. (2006). Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: A review. Vaccine, 24(13), 2440-2448.
DOI Scopus27 WoS21 Europe PMC21 |
| 2005 |
Marshall, H., Ryan, P., & Roberton, D. (2005). Uptake of varicella vaccine - A cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine, 23(46-47), 5389-5397.
DOI Scopus32 WoS33 Europe PMC28 |
| 2005 |
Roberton, D., Marshall, H., Nolan, T., Sokal, E., Diez-Domingo, J., Flodmark, C., . . . Stoffel, M. (2005). Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine, 23(43), 5099-5105.
DOI Scopus16 WoS9 Europe PMC9 |
| 2005 |
De Almeida, M. D. V., Davidson, K., De Morais, C., Marshall, H., Bofill, S., Grunert, K. G., . . . Lumbers, M. (2005). ALCOHOL CONSUMPTION IN ELDERLY PEOPLE ACROSS EUROPEAN COUNTRIES: RESULTS FROM THE FOOD IN LATER LIFE PROJECT. AGEING INTERNATIONAL, 30(4), 377-395.
WoS3 |
| 2004 |
Isaacs, D., Kilham, H., & Marshall, H. (2004). Should routine childhood immunizations be compulsory?. Journal of Paediatrics and Child Health, 40(7), 392-396.
DOI Scopus20 WoS19 Europe PMC14 |
| 2004 |
Roberton, D., Marshall, H., Dinan, L., Boros, C., & Gold, M. (2004). Developmental immunology and vaccines: immune responses to vaccines in premature infants. Expert Review of Vaccines, 3(4), 343-347.
DOI Scopus7 Europe PMC6 |
| 2004 |
Belshe, R., Newman, F., Anderson, E., Wright, P., Karron, R., Tollefson, S., . . . Tsai, T. (2004). Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. Journal of Infectious Diseases, 190(12), 2096-2103.
DOI Scopus75 WoS52 Europe PMC47 |
| 2004 |
Belshe, R., Newman, F., Tsai, T., Karron, R., Reisinger, K., Roberton, D., . . . Anderson, E. (2004). Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. Journal of Infectious Diseases, 189(3), 462-470.
DOI Scopus58 WoS41 Europe PMC33 |
| - |
Leong, L. E. X., Coldbeck-Shackley, R. C., McMillan, M., Bratcher, H. B., Turra, M., Lawrence, A. J., . . . Marshall, H. S. (n.d.). Effect of 4cmenb Vaccination on the Genomic Epidemiology of Neisseria Meningitidis Oropharyngeal Carriage in an Asymptomatic Adolescent Population. |
| - |
Wood, N., Wadia, U., Richmond, P., Argent, C., Marshall, H. S., Sandgren, K. J., . . . Cunningham, A. L. (n.d.). A Phase I, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Trial to Study the Safety and Immunogenicity of a DNA-Based Vaccine Against COVID-19 (COVIGEN) in Healthy SARS-CoV-2 Vaccine-Naïve Participants Aged 18 to 59 Years Old. |
| - |
Lucas, R. D., Britton, P., Wood, N., Cheng, A. C., Marshall, H. S., Wadia, U., . . . Burgner, D. (n.d.). Presentation and Management of Kawasaki Disease in Australia, 2019–21: A Multicentre Prospective Cohort Study. |
